AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Margenthaler, JA Virgo, KS Johnson, DY Sugarbaker, EM Handler, BS Johnson, FE
Citation: Ja. Margenthaler et al., How surgeon age affects post-treatment surveillance strategies for melanoma patients, INT J ONCOL, 19(1), 2001, pp. 175-180

Authors: Margenthaler, JA Yu, S Otomo, N Shimizu, Y Fiye, MW
Citation: Ja. Margenthaler et al., Portal venous tolerance in the anti-class I L-d alloantigen 2C transgenic mouse, TRANSPLAN P, 33(1-2), 2001, pp. 143-144

Authors: Shimizu, Y Otomo, N Yu, S Margenthaler, JA Flye, MW
Citation: Y. Shimizu et al., Donor-specific antigen transfusion-mediated cardiac allograft tolerance isprevented by prior treatment with anti-CD8, but not anti-CD4, antibody, TRANSPLAN P, 33(1-2), 2001, pp. 150-151

Authors: Otomo, N Motoyama, K Yu, S Shimizu, Y Margenthaler, JA Tu, F Flye, MW
Citation: N. Otomo et al., Intrathymic alloantigen-mediated tolerant, completely MHC-mismatched mousehearts are specifically rejected by adoptively transferred in vitro-sensitized anti-class I Ld+-specific 2C cells, TRANSPLAN P, 33(1-2), 2001, pp. 159-160

Authors: Margenthaler, JA Otomo, N Shimizu, Y Yu, S Flye, MW
Citation: Ja. Margenthaler et al., Delayed type hypersensitivity in the CD8+dominant anti-class I L-d alloantigen 2C transgenic mouse is mediated by small but significant CD4 population, TRANSPLAN P, 33(1-2), 2001, pp. 338-339

Authors: Margenthaler, JA Tu, F Otomo, N Shimizu, Y Yu, S Flye, MW
Citation: Ja. Margenthaler et al., Immunogenicity of Ld+ transgenic mouse hearts, SURGERY, 130(2), 2001, pp. 217-224

Authors: Otomo, N Margenthaler, JA Motoyama, K Arima, T Shimizu, Y Lehmann, M Flye, MW
Citation: N. Otomo et al., Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration, J SURG RES, 98(1), 2001, pp. 59-65
Risultati: 1-7 |